AXGN
AxoGen, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$48.28
+2.51%Aug 3, 2026, 06:37 UTC
Axogen received FDA biologic approval for Avance, granting 12 years of exclusivity.
Source:Jul 29, 2026, 11:10 UTC
Trace Biosciences announces a strategic investment from Axogen to advance clinical development of its Nerve Trace nerve-specific imaging technology.
Source:Jul 29, 2026, 11:05 UTC
Axogen, Inc. reported its financial results for the second quarter of 2026.